T2 Biosystems

Update in progress

TTOO (OTC Markets OTCPK)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

T2 Biosystems, Inc. develops and commercializes diagnostic tests for critical unmet health needs. Its portfolio includes the T2Dx instrument, the T2Candida panel, and the T2Bacteria panel, designed for rapid, direct-from-blood testing. Founded in 2006, the company is based in Lexington, Massachusetts. T2 Biosystems focuses on improving infection diagnosis and patient outcomes through rapid, actionable results.

Company score

Sentiment: -0.53; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.61; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.25; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.24; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.38; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive